Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Other Accumulated Expenses (2020 - 2025)

BioAtla (BCAB) has disclosed Other Accumulated Expenses for 6 consecutive years, with $842000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 19.27% year-over-year to $842000.0; the TTM value through Dec 2025 reached $842000.0, down 19.27%, while the annual FY2025 figure was $842000.0, 19.27% down from the prior year.
  • Other Accumulated Expenses hit $842000.0 in Q4 2025 for BioAtla, up from $509000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.8 million in Q2 2022 and bottomed at $509000.0 in Q3 2025.
  • Average Other Accumulated Expenses over 5 years is $851850.0, with a median of $844500.0 recorded in 2022.
  • Year-over-year, Other Accumulated Expenses skyrocketed 181.49% in 2022 and then plummeted 50.59% in 2023.
  • BioAtla's Other Accumulated Expenses stood at $1.1 million in 2021, then grew by 19.2% to $1.3 million in 2022, then plummeted by 32.37% to $865000.0 in 2023, then grew by 20.58% to $1.0 million in 2024, then decreased by 19.27% to $842000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $842000.0, $509000.0, and $715000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.